Antoni Wiedlocha funded by the EEA Poland-Norway grants
Antoni Wiedlocha
The proposal "Novel targeted therapy based on dual warhead conjugates against FGFR dependent cancers", with senior scientist Antoni Wiedlocha at Department of Molecular Cell Biology, Institute for Cancer Research, as Norwegian partner and professor Jacek Otlewski at the University of Wroclaw as Polish parther, has been awarded funding from the EEA Poland-Norway grants under the "Applied Research" programme.
Links:
From the National Centre for Research and Development in Poland:
Published in Level 2 journals, first or last author from Oslo University Hospital.
Noreng L, Øiestad ÅML, Hansen FA, Røberg-Larsen H, Wilson SR, Øiestad EL(2026) Toward Sustainable Clinical Analysis: Benchmarking Plastic Use in LC-MS Sample Preparation - Exemplified by Ketamine Analogues in Whole Blood Anal Chem(in press) DOI 10.1021/acs.analchem.5c08225, PubMed 41972595
Simensen R, Rehn M, Hagemo J, Fjose LO, Heyerdahl F(2026) Methoxyflurane: analgesic benefit and environmental impact - Authors' reply Lancet, 407(10537), 1427-1428 DOI 10.1016/S0140-6736(26)00495-2, PubMed 41969009
Ulvestad DA, Ekberg A, Bakali JV, Eikenæs IU, Fjermestad-Noll J, Hjermann E, Hummelen B, Morken KTE, Oftedal E, Zahl KE, Øvrebø M, Pedersen G, Wilberg T, Kvarstein EH(2026) Improvement of emotional dysregulation, aggression, and self-harm among people treated within outpatient personality disorder mental health services. A large longitudinal, observational, multi-centre study Psychother Res, 1-18(in press) DOI 10.1080/10503307.2026.2650154, PubMed 41961731